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Aims Apical rocking (ApRock) and septal flash (SF) are often observed phenomena in asynchronously contracting ventricles.
We investigated the relationship of visually assessed ApRock and SF, reverse remodelling, and long-term survival in
cardiac resynchronization therapy (CRT) candidates.
Methods
and results
A total of 1060 patients eligible for CRT underwent echocardiographic examinations before and 12+ 6 months after
device implantation. Three blinded physicians were asked to visually assess the presence of ApRock and SF before de-
vice implantation and also their correction by CRT 12+6 months post-implantation. Patients with a left ventricular
(LV) end-systolic volume decrease of ≥15% during the first year of follow-up were regarded as responders. Patients
were followed for a median period of 46 months (interquartile range: 27–65 months) for the occurrence of death of
any cause. If corrected by CRT, visually assessed ApRock and SF were associated with reverse remodelling with a sen-
sitivity of 84 and 79%, specificity of 79 and 74%, and accuracy of 82 and 77%, respectively. ApRock (hazard ratio [HR]
0.40, 95% confidence interval [CI] 0.30–0.53, P, 0.0001) and SF (HR 0.45 [CI 0.34–0.61], P, 0.001) were independ-
ently associated with lower all-cause mortality after CRT and had an incremental value over clinical variables and QRS
width for identifying CRT responders. Both the absence of ApRock/SF and unsuccessful correction of ApRock/SF des-
pite CRT were associated with a high risk for non-response and an unfavourable long-term survival.
Conclusion A specific LV mechanical dyssynchrony pattern, characterized by ApRock and SF, is associated with a more favourable
long-term survival after CRT. Both parameters are also indicators of an effective therapy.
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Introduction
Cardiac resynchronization therapy (CRT) has become an estab-
lished treatment option for patients with left ventricular ejection
fraction (LVEF) of ≤35%, QRS duration of ≥120 ms, and symptom-
atic heart failure resistant to optimal medical therapy, but more than
a third of patients fulfilling these current guideline criteria do not
benefit from this costly treatment.1 Since the principal therapeutic
target of CRT is resynchronization of discoordinate ventricular con-
traction,2,3 it has been hypothesized that the assessment of mechan-
ical dyssynchrony could improve identification of patients likely to
respond to CRT, irrespective of QRS duration.4 – 7 Over the past
decade, a plethora of methods to assess mechanical dyssynchrony
has been suggested, but, so far, patient selection by mechanical mea-
sures of dyssynchrony, in both wide and narrow QRS, could not
provide a sufficient added value to refine or expand guideline cri-
teria for CRT.1,8,9 Most of previously suggested methods are based
on the analysis of timing of longitudinal myocardial velocity peaks
which may not be truly reflective of mechanical events in dyssyn-
chronously contracting ventricles,3,10 particularly in patients with is-
chaemic cardiomyopathy.11 Furthermore, a prospective multicentre
study raised serious doubts regarding the feasibility, reproducibility,
and robustness of these parameters in a routine clinical setting.8
Visual assessment of cardiac dyssynchrony by apical rocking
(ApRock) is a novel approach to assess left ventricular (LV) mech-
anical dyssynchrony with a potential for circumventing the limita-
tions of previously proposed parameters.11 – 13 ApRock is
characterized by a short septal motion of the apex due to the con-
traction of the septum early in systole and a subsequent long motion
to the lateral side during ejection due to the late lateral contraction
caused by the left bundle branch block (LBBB). The early contrac-
tion of the septum can also result in its rapid short inward motion,
which has been referred to as ‘septal beaking’ or ‘septal flash’ (SF) in
previous publications.14,15 Both ApRock and SF are therefore direct
consequences of the mechanical dyssynchrony induced by the
LBBB. Their ability to characterize mechanical dyssynchrony has al-
ready been shown in prospective observational studies demonstrat-
ing their superiority to conventional parameters.11,14,16 ApRock and
SF can be easily visually assessed on conventional two-dimensional
echocardiographic images, surpassing the need for expensive soft-
ware and sophisticated myocardial velocity or strain analysis.11,13,14
We initiated a multicentre observational study (PREDICT-CRT)
to investigate the relationship of a simple visual assessment of
ApRock and SF and their effective correction by CRT to both re-
sponse and long-term survival following CRT.
Methods
Study population
We analysed data from 1060 heart failure patients treated with CRT be-
tween March 1999 and October 2012, retrospectively collected from
six European centres (detailed enrolment data are provided in Supple-
mentary data online). Inclusion criteria were LVEF of ≤35%, QRS dur-
ation of ≥120 ms, NYHA functional class II – IV, and optimal
pharmacotherapy at least 3 months before CRT. Ischaemic origin of heart
failure was proved by coronary angiography or by a documented history
of myocardial infarction. Patients with ischaemic cardiomyopathy had
undergone revascularization procedures before they were considered
for CRT implantation. Patients with ischaemic heart disease unsuitable
for revascularization were also included, provided that there were no
angina symptoms with optimal pharmacological therapy. At the time of
CRT implantation, none of the candidates required surgical or inter-
ventional revascularization for symptomatic coronary disease. Inclu-
sion further required the availability of standard two-dimensional
echocardiographic image loops from the apical and parasternal win-
dows prior to CRT implantation and 12+ 6 months thereafter.
Data on mortality were collected from medical records, by interview
with the patients’ general practitioner or relatives, and/or from nation-
al death registries. For the assessment of the association of long-term
survival and ApRock/SF regardless of correction by CRT, patients
were followed from the time of CRT implantation; for the assessment
of survival of patients with corrected, uncorrected, and no ApRock/SF,
the starting point of follow-up was the time of follow-up echo
examination.
Patients’ flow through the study is shown in Supplementary data
online, Figure S1. The study was approved by the ethical committee of
the University Leuven which also waived the requirement to obtain
informed consents due to the retrospective and non-interventional
nature of the study.
Echocardiographic data acquisition and
analysis
Echocardiographic data were acquired using commercially available
scanners (Vivid 5, 7, and E9, GE Vingmed Ultrasound, Horton, Norway).
Digitally stored image loops were analysed off-line using EchoPac work-
stations. Readers had only access to the greyscale image loops and were
blinded to any other patient data. Baseline and post-implant data of one
patient were read separately and blinded to the results of the respective
other examination, but by the same reader.
Assessment of conventional echo parameters
The analysis of conventional echo parameters comprised the LV vo-
lumes and ejection fraction, which were calculated using the modified
biplane Simpson method.
Visual assessment of ApRock and SF
The presence of ApRock and SF was visually assessed pre- and 12+6
months post-CRT implantation. Six readers from three of the participat-
ing centres with 3–10 years of experience in echocardiography were in-
volved. They had been trained in ApRock and SF assessment with 10
example datasets, which were not part of the study. All readings were
initially performed by two readers. A blinded third reader was asked in
case of disagreement, allowing a majority decision (Figure 1 and Supple-
mentary data online, Video S1–S3).
Assessment of myocardial scar
In the participating centres, the extent and location of myocardial scar
was assessed based on MRI and scintigraphy or coronary disease was ex-
cluded by a negative coronary angiogram prior to device implantation. In
combination with the assessment of ApRock and SF, readers were add-
itionally asked to consider echocardiographic signs of scar, such as akin-
esia or dyskinesia in thin and hyperechogenic segments for their
prediction of response. These observations were noted using a modi-
fied 18-segment model of the left ventricle (three segments per wall)
and the mean of the number of scarred segments identified by two read-
ers was used.
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Cardiac resynchronization therapy
All patients received a biventricular pacemaker, in 399 (40%) with defib-
rillator. LV pacing leads were positioned, guided by coronary venog-
raphy, preferably in lateral and posterolateral venous branches.
Device settings were optimized within a week of CRT device implant-
ation based, as deemed clinically appropriate, on surface ECG and Dop-
pler echocardiography.17 Patients with an LV end-systolic volume
decrease of ≥15% during follow-up were regarded as responders.18
Statistical analysis
Details may be found in Supplementary data online. In short, continuous
data are expressed as mean+ standard deviation and groups were com-
pared with a two-sample t-test. In case of serious deviation from normal
distribution, median and interquartile range (IQR) and a Wilcoxon rank-
sum test were used. Categorical data were summarized by their observed
frequencies and percentages, and compared using a Fisher’s exact test.
The discriminative power of ApRock for the prediction of CRT response
was analysed by the area (AUC) under the receiver operating character-
istic curve and its added discriminative power was tested using c-statistics.
Survival rates were estimated using the Kaplan–Meier method, and differ-
ences were tested by a log-rank test. Prediction of survival was investi-
gated using Cox regression models. Intraobserver variability was tested
in 100 randomly selected patients and interobserver variability in the
whole study population using Kappa statistics. All statistical tests were
two-tailed, applying a significance level of 5%. Confidence intervals
(CIs) are given for 95%. We used SAS for Windows (version 9.2, SAS In-
stitute, Cary, NC, USA) and R statistical software (version 3.02, University
of Auckland, Auckland, New Zealand) for our analyses.
Results
Characteristics of the study population are summarized in Table 1
and Supplementary data online, Tables S1 and S2. Intraobserver
agreement for visual assessment of ApRock and SF was 93%
(k ¼ 0.81 [CI 0.66–0.95]) and 93% (k ¼ 0.80 [CI 0.66–0.95]), re-
spectively, and interobserver agreement was 86% (k ¼ 0.71 [CI
0.67–0.76] for both ApRock and SF).
ApRock, SF, and response to CRT
Patients who responded to CRT (58%) were more frequently wo-
men, had more often non-ischaemic cardiomyopathy, LBBB
Figure 1 Typical sequence of mechanical (top panels) and electrical (bottom panel) events in LBBB. An early electrical activation of the septum
results in a short initial septal contraction and causes the apex to move septally while the septum moves leftward (SF, yellow arrow in the middle
panel). The delayed activation of the lateral wall pulls then the apex laterally during the ejection phase while stretching the septum. This typical
sequence of the septal-to-lateral apex motion is described as ‘ ApRock’. The septal inward motion is described as ‘SF’.
Table 1 Baseline clinical and echocardiographic data
Age, years (n ¼ 1058) 64+11
Female sex, n (%) (n ¼ 1060) 255 (24)
NYHA functional class (n ¼ 1019) 2.9+0.5
Ischaemic aetiology, n (%) (n ¼ 1048) 455 (43)
QRS width, ms (n ¼ 974) 170+29
LBBB, n (%) (n ¼ 976) 862 (88)
Atrial fibrillation, n (%) (n ¼ 1038) 261 (25)
ACEi/ARB, n (%) (n ¼ 957) 920 (96)
b-blockers, n (%) (n ¼ 965) 888 (92)
Aldosterone antagonists, n (%) (n ¼ 959) 721 (75)
LVEF, % (n ¼ 883) 27+7
Left ventricular end-systolic diameter, mm (n ¼ 918) 60+21
Left ventricular end-diastolic diameter, mm (n ¼ 929) 68+10
Left ventricular end-systolic volume, mL (n ¼ 883) 164+71
Left ventricular end-diastolic volume, mL (n ¼ 883) 223+84
Scar burden, segments 0.78+1.94
ACEi/ARB, angiotensin-converting enzyme inhibitor/angiotensin II receptor
blocker; NYHA, New York Heart Association.
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morphology, and wider QRS complexes (see Supplementary data
online, Table S3). ApRock was observed in 64% of patients (vs.
63% for SF)—among these, both ApRock and SF were observed
in 83% of patients, whereas either SF or ApRock alone was seen
in 8.4 and 8.6% of patients, respectively. A volumetric response
rate was 77% when both ApRock and SF were present, 69% if
only ApRock was seen and 56% if only SF was present.
Patients with ApRock/SF were younger, more frequently female,
had more often LBBB morphology and greater QRS duration, less
ischaemic disease, and less atrial fibrillation. Of note, ApRock was
observed in 69% of patients with LBBB (vs. 70% for SF), and 76%
of these responded to CRT (vs. 75% for SF). Only 18% of patients
with LBBB were volumetric responders (83% male, 76% in sinus
rhythm, 61% non-ischaemic HF, and 77% in NYHA III class) if neither
ApRock nor SF was observed. In addition, ApRock was observed in
26% of patients without LBBB (vs. 20% for SF), most of whom (63%
with ApRock and 62% with SF) responded to CRT.
ApRock and SF were not corrected by CRT in 9 and 8% of pa-
tients, respectively, most of whom (80 and 70%, respectively) did
not respond to CRT. Patients with uncorrected ApRock had lower
LVEF (26+ 6 vs. 23+ 5%, P, 0.001) and larger LV end-diastolic
volumes (274+ 101 vs. 222+ 83 mL, P, 0.001) and diameters
(75+ 10 vs. 68+ 10 mm, P, 0.001) than those with corrected
ApRock.
ApRock corrected by CRT was highly sensitive (84%, CI 80–88%)
and specific (79%, CI 73–83%) for identifying volumetric response
to CRT (AUC 0.82, CI 0.79–0.85, P, 0.001). Likewise, if corrected
by CRT, SF showed a good sensitivity (79%, CI 75–83%) and speci-
ficity (74%, CI 69–79%) for predicting response to CRT (AUC 0.77,
CI 0.73–0.80, P, 0.001).
ApRock corrected by CRT had a significant incremental value
over clinical variables (age, gender, presence of LBBB, NYHA class,
ischaemic aetiology, atrial fibrillation, QRS width, baseline LVEF, and
LVEDD) for the prediction of CRT response. The c-statistic index
for a prediction model increased significantly by adding ApRock
(0.69 vs. 0.82; change in the c-statistics 0.134, CI 0.100–0.168,
P, 0.001; Figure 2 and Supplementary data online, Table S4). Similar
data on SF are provided in Supplementary data online, Figure S2 and
Table S5.
ApRock and long-term survival following
CRT
During a median follow-up of 46 months (IQR 27–65), 236 (25%) of
943 patients died. Furthermore, 72 patients (6.8%) died during the
first 12 months of CRT implantation. These patients had similar base-
line LVEF (26+6 vs. 26+7%, P ¼ 0.743) and QRS width (166+36
vs. 170+ 29 ms, P ¼ 0.397) as those who lived .12 months, but
were older (mean age 67+ 12 vs. 64+ 11 years, P ¼ 0.025), and
more frequently had atrial fibrillation (44 vs. 24%, P ¼ 0.001) and is-
chaemic origin of cardiomyopathy (58 vs. 42%, P ¼ 0.001). This sub-
group of patients also showed a lower prevalence of LBBB (72 vs.
89%, P, 0.001) and ApRock (44 vs. 65%, P ¼ 0.002).
The vital status was available in all patients, but 118 patients (in
case of ApRock) and 116 patients (in case of SF) were excluded
from survival analysis due to unavailability of corresponding dyssyn-
chrony assessment either on baseline or on follow-up visit. The
baseline characteristics of these patients and the comparison with
the rest of the study population are shown in Supplementary data
online, Table S6. Importantly, patients excluded from survival ana-
lysis due to missing dyssynchrony assessments had survival rates
similar to those included into analysis (see Supplementary data on-
line, Figure S3). Patients with ApRock/SF before CRT implantation
had a significantly more favourable overall survival than those with-
out (log-rank P, 0.001; Figure 3). Our data indicate further that pa-
tients with successfully corrected ApRock had a significantly more
favourable overall survival than both those without ApRock and
those retaining ApRock despite CRT (log-rank P, 0.001 for
both; Figure 4A). Of note, there was no significant difference in long-
term outcome between the latter two groups (log-rank P ¼ 0.864).
Cox proportional hazards analysis identified ApRock, age, female
sex, NYHA class, b-blocker use, and baseline LVEF as parameters in-
dependently associated with all-cause mortality (Table 2). Data on
relationship of SF and long-term survival are provided in Supplemen-
tary data online, Tables S7, S8, and Figure S4A. Continuous net reclas-
sification improvement of all-cause mortality risk for both corrected
ApRock and SF is shown in Supplementary data online, Table S8.
To compare the added value of ApRock correction over LV re-
verse remodelling to predict the course of disease after the first
follow-up visit, volumetric response to CRT was added to the multi-
variate model with corrected ApRock. In this test, response to CRT
reached an HR of 0.533; 95% CI 0.375–0.757; P ¼ 0.0005, without
significantly affecting HR of corrected ApRock (HR 0.405; 95% CI
0.283–0.579; P, 0.0001). Similar data were obtained for SF (HR
0.465; 95% CI 0.338–0.638; P, 0.0001) and reverse remodelling
(HR 0.480; 95% CI 0.342–0.675; P, 0.0001).
Figure 2 Added predictive value of corrected ApRock for the
prediction of volumetric response. Model 1 is a logistic regression
model that includes gender, LBBB, b-blockers, age, NYHA func-
tional class, ischaemic aetiology, atrial fibrillation, scar burden, LV
end-diastolic diameter, LVEF, and implantable cardioverter defib-
rillator, and is nested in Models 2 and 3. The addition of QRS width
(Model 2) did not provide incremental information over baseline
clinical variables, whereas further addition of corrected ApRock
(Model 3) resulted in an incremental predictive value for the pre-
diction of volumetric response.
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ApRock and SF in patients with a QRS
duration of <150 ms
Separate analysis was performed to examine the potential of
ApRock and SF to identify CRT responders among patients with
QRS width below 150 ms (n ¼ 194). The prevalence of ApRock in
this subgroup of patients was 41% (vs. 37% for SF), and if corrected
by CRT, it identifies volumetric responders to CRT with a sensitivity
of 76% (CI 66–85%) and a specificity of 88% (CI 79–94%; AUC 0.83,
Figure 3 Kaplan–Meier curves depicting long-term survival after CRT. Patients with ApRock (A) and SF (B) had a more favourable long-term
survival than those without ApRock and SF.
Figure 4 Kaplan–Meier curves depicting long-term survival after CRT in the whole study population (A) and the subpopulation of patients with
intermediate (,150 ms) QRS duration (B). In both populations, patients with corrected ApRock had a more favourable long-term survival than
those without ApRock and those retaining ApRock despite CRT.
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CI 0.76–0.90, P, 0.001). Similarly, SF corrected by CRT results in a
sensitivity of 69% (CI 58–79%) and a specificity of 89% (CI 80–95%;
AUC 0.77, CI 0.70–0.85, P, 0.001).
Similar to patients with QRS of ≥150 ms, patients with QRS of
,150 ms and corrected ApRock or SF had a more favourable over-
all survival than both those without ApRock or SF and those retain-
ing ApRock or SF after CRT (log-rank: for ApRock P ¼ 0.0019 and
for SF P ¼ 0.0134; Figure 4B and Supplementary data online, Figure
S4B). Also, in patients with both wide and intermediate QRS, cor-
rected ApRock or SF was associated with lower all-cause mortality
(Figure 5 and Supplementary data online, Figure S5).
Discussion
In one of the largest series of heart failure patients undergoing echo-
cardiographic dyssynchrony evaluation prior to CRT implantation,
we investigated the association of visual assessment of ApRock
and SF on routine echocardiograms and long-term survival. Our
findings demonstrate that visually assessed ApRock and SF, as surro-
gate markers of mechanical dyssynchrony, are strongly associated
with both volumetric response and favourable long-term survival
after CRT. We also found that not only the presence but also the
correction of ApRock and SF was the prerequisite for a lower all-
cause mortality after CRT. Our data show further that the observed
correction of ApRock during the first follow-up visit has a higher
predictive value for further patient outcome than LV reverse re-
modelling. This is in agreement with earlier studies.19
Although several other studies had suggested advantages in pa-
tient outcome,14,16,20 – 25 current clinical guidelines do not recom-
mend the assessment of mechanical dyssynchrony in CRT
candidates.1 Despite criticism regarding its methodology,26,27 the
PROSPECT trial8 had caused many concerns about the accuracy
and reproducibility of echocardiographic methods to detect
mechanical dyssynchrony. The results of the present study strongly
support the association between LV mechanical dyssynchrony and
long-term outcome after CRT, and show that our visual assessment
approach might surpass the limitations of dyssynchrony measure-
ments addressed in the previous studies.
The majority of previously proposed echocardiographic para-
meters are derived from tissue-Doppler-based time-to-peak-
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Univariate and multivariate regression analyses to identify parameters associated with all-cause mortality
Univariate Multivariable
HR [95% CI] P-value HR [95% CI] P-value
ApRock (yes/no) 0.346 [0.272–0.441] ,0.0001 0.400 [0.304–0.526] ,0.0001
Female sex 0.501 [0.363–0.693] ,0.0001 0.700 [0.494–0.992] 0.0452
LBBB 0.575 [0.399–0.829] 0.0030 0.690 [0.426–1.115] 0.1296
Age (years) 1.037 [1.024–1.051] ,0.0001 1.028 [1.014–1.042] 0.0001
NYHA functional class 1.852 [1.416–2.424] ,0.0001 1.734 [1.321–2.277] ,0.0001
QRS width (ms) 0.998 [0.993–1.002] 0.3071 0.999 [0.994–1.004] 0.7967
Ischaemic aetiology 1.951 [1.533–2.483] ,0.0001 1.261 [0.948–1.678] 0.1109
Scar burden (scarred segments) 1.103 [1.039–1.171] 0.0013 0.991 [0.923–1.064] 0.7950
Atrial fibrillation 1.586 [1.221–2.062] 0.0006 1.272 [0.961–1.684] 0.0921
b-blockers 0.549 [0.369–0.817] 0.0031 0.626 [0.412–0.950] 0.0279
ICD 1.093 [0.839–1.424] 0.5114 0.867 [0.643–1.169] 0.3490
LVEF at baseline (%) 0.990 [0.970–1.010] 0.3206 0.972 [0.950–0.994] 0.0146
LVEDD at baseline (mm) 0.998 [0.986–1.010] 0.7286 1.004 [0.989–1.020] 0.5787
Missing data are accounted for using multiple imputation, so all 1060 patients are included in the analysis.
CI, confidence interval; ICD, implantable cardioverter defibrillator; HR, hazard ratio; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; NYHA,
New York Heart Association.
Figure 5 Long-term survival following CRT in patients with
wide (≥150 ms) and intermediate (,150 ms) QRS duration. Cor-
rection of ApRock by CRT was associated with better survival in
patients with both wide and intermediate QRS duration.
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velocity measurements and may also detect dyssynchrony in the
presence of heterogeneous intraventricular activation sequences
not treatable by CRT.28,29 In contrast to this, ApRock and SF are epi-
phenomena, specific for a typical LBBB-induced contraction pattern
of the LV, which may explain that their predictive value for CRT
response is superior.11,14 While the concept of ApRock and SF is
different from that of tissue-Doppler-derived dyssynchrony para-
meters, it may be comparable with that of other, recently proposed
quantitative dyssynchrony parameters reflective of LBBB-induced
motion pattern, such as regional strain pattern analysis,21 anterosep-
tal to posterior time-to-peak radial strain difference,30 and poten-
tially also to cross-correlation analysis.25
Our data imply that a trained human eye can easily detect a typical
early septal movement and a septal-to-lateral apical motion pattern
induced by an LBBB. Visual function assessment is not uncommon
among experienced echocardiographers. It correlates well with for-
mal methods of quantification31 and is in several fields (i.e. stress
echocardiography), even the guideline-recommended method for
decision-making.32 Nevertheless, clinical utility of ApRock and SF
could potentially be limited by interobserver disagreement, which
is most often observed in patients with borderline dyssynchrony.13
In such cases, a low-dose dobutamine challenge may be used to un-
mask or potentiate LV dyssynchrony.16,33
The current study showed that mechanical dyssynchrony, as indi-
cated by ApRock and SF, was strongly associated with a lower mor-
tality after CRT, but also confirmed that reasons other than the lack
of mechanical dyssynchrony might be responsible for non-response
to CRT. Patients with male gender, ischaemic cardiomyopathy, and
higher NYHA class were less likely to benefit from CRT. Further-
more, we observed 18% of volumetric responders among patients
with LBBB and no ApRock and SF. However, the observed un-
favourable response and survival of patients retaining ApRock and
SF despite CRT suggest that correction of mechanical dyssynchrony
is, indeed, the primary therapeutic principle behind CRT and under-
lines the need for dyssynchrony assessment during CRT patient
follow-up. The reasons for failures of CRT to correct ApRock
were not investigated in this study and it can only be speculated
that lead dysfunction, advanced heart failure, suboptimal lead place-
ment, and insufficient biventricular pacing were the potential rea-
sons.34 Nevertheless, according to our data, patients with
ineffective resynchronization are at high risk for unfavourable out-
come. The potential benefit of CRT optimization or reimplantation
(e.g. surgical epicardial LV lead implantation) in this subset of pa-
tients may be concluded from experience with individual patients,
but remains to be proved.
Clinical implications
Only strong evidence from randomized trials demonstrating super-
iority of mechanical dyssynchrony over routine ECG-based criteria
could change current patient selection for CRT. However, rando-
mized trials to clarify this point are considered unethical due to a
relatively high plausibility of response in patients with a very wide
QRS width (≥150 ms).23,25 On the other hand, the need for a bet-
ter patient selection in a subgroup with an intermediate QRS dur-
ation was clearly underlined by a recent meta-analysis of the five
randomized CRT trials, suggesting that patients with QRS of 120–
149 ms would not benefit from CRT.35 Our data not only demon-
strated an association of ApRock/SF and better long-term survival,
but also showed that ApRock and SF were able to identify respon-
ders to CRT among patients with QRS duration of ,150 ms with a
fair sensitivity and an excellent specificity. However, a randomized
trial or retrospective analysis of previous randomized trials investi-
gating the predictive power of ApRock and SF for CRT response in
this subgroup of patients is needed before the refinement of clinical
practice guidelines by the assessment of mechanical dyssynchrony
can be suggested. Finally, our data show that inefficient CRT is asso-
ciated with worse outcome. This suggests that the assessment of
mechanical dyssynchrony before and after CRT to identify and treat
such patients could be of added clinical value.
Study limitations
This study was not randomized, and the relationship of ApRock and
SF and, therefore, the treatment outcome in patients who did not
undergo CRT remain unknown. Furthermore, although the scar
burden was expectedly associated with unfavourable outcome in
our study, our data suggest that myocardial infarct scar assessment
based on echocardiography alone is suboptimal and should possibly
be complemented by imaging modalities with higher accuracy for
detecting scar. Using contrast-enhanced cardiac magnetic reson-
ance imaging, we recently showed that myocardial scar burden is
an important determinant of response to CRT.16 More recently,
we could show that LV motion patterns are dominated by conduc-
tion delays, but also modulated by infarct scar resulting in less
pronounced ApRock in patients with a high scar burden.36 Further-
more, volumetric response to CRT among patients without
ApRock/SF could be explained by other approaches for assessing
cardiac dyssynchrony, including LV filling patterns, LV pre-ejection
time, and interventricular mechanical dyssynchrony, which were
not the part of this study.14,37
Finally, analysis of other factors known to influence CRT re-
sponse, such as discordant LV lead position and myocardial scar in
the region of the LV pacing lead, was not part of this study.20,34
Conclusions
A specific LV mechanical dyssynchrony pattern, characterized by
ApRock and SF, is associated with a more favourable long-term sur-
vival after CRT. Both parameters are also indicators of an effective
therapy.
Supplementary data
Supplementary data are available at European Heart Journal – Cardio-
vascular Imaging online.
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